Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
NCT ID: NCT03026192
Last Updated: 2019-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
4 participants
OBSERVATIONAL
2016-12-31
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Invasive Detection of Tissue Oxygen Deprivation in Premature Infants With Patent Ductus Arteriosus.
NCT03277768
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
NCT03551600
NIRS in PDA VLBW Infants
NCT02396004
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
NCT03782610
Plasma N-terminal proBNP Concentrations and Patent Ductus Arteriosus in Preterm Babies
NCT00725647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no PDA
These are infants who do not have a patent ductus arteriosus (PDA) as determine by echocardiography
near infrared spectroscopy
Near infrared spectroscopy will be placed on infants both with and without hsPDA
hsPDA
These are infants who have a hemodynamically significant PDA (hsPDA) as determined by echocardiography
near infrared spectroscopy
Near infrared spectroscopy will be placed on infants both with and without hsPDA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
near infrared spectroscopy
Near infrared spectroscopy will be placed on infants both with and without hsPDA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Minute
1 Week
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Albany Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Tauber
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Albany Medical Center Neonatal Intesive Care Unit
Albany, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4585
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.